HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Claudia Lanari Selected Research

Progestins (Progestagens)

1/2013Targeting progesterone receptors in breast cancer.
5/2012Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
1/2012[The role of estrogen receptor alpha in breast cancer cell proliferation mediated by progestins].
5/2011Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancer.
4/2011Classical membrane progesterone receptors in murine mammary carcinomas: agonistic effects of progestins and RU-486 mediating rapid non-genomic effects.
1/2010Inoculated mammary carcinoma-associated fibroblasts: contribution to hormone independent tumor growth.
1/2010Responsiveness to PI3K and MEK inhibitors in breast cancer. Use of a 3D culture system to study pathways related to hormone independence in mice.
1/2010Mifepristone inhibits MPA-and FGF2-induced mammary tumor growth but not FGF2-induced mammary hyperplasia.
12/2008Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis.
6/2003Progesterone receptor expression in medroxyprogesterone acetate-induced murine mammary carcinomas and response to endocrine treatment.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Claudia Lanari Research Topics

Disease

32Neoplasms (Cancer)
01/2016 - 01/2002
27Breast Neoplasms (Breast Cancer)
09/2015 - 01/2002
26Carcinoma (Carcinomatosis)
09/2015 - 05/2002
3Breast Ductal Carcinoma
06/2009 - 05/2002
2Neoplasm Metastasis (Metastasis)
05/2013 - 06/2005
2Body Weight (Weight, Body)
04/2011 - 01/2005
2Ductal Carcinoma
06/2009 - 05/2009
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2016
1Hyperplasia
01/2010
1Disease Progression
01/2010
1Adenocarcinoma
05/2009
1Aneuploidy (Aneuploid)
09/2005

Drug/Important Bio-Agent (IBA)

24Progesterone Receptors (Progesterone Receptor)IBA
06/2015 - 01/2002
22HormonesIBA
05/2013 - 05/2002
14Estrogens (Estrogen)FDA Link
06/2012 - 01/2002
12Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric
03/2012 - 05/2002
11Progestins (Progestagens)IBA
01/2013 - 01/2002
7Mifepristone (RU 486)FDA Link
06/2015 - 01/2005
6Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
01/2016 - 12/2008
6ProgesteroneFDA LinkGeneric
05/2012 - 01/2002
5Estrogen Receptor alphaIBA
06/2012 - 01/2005
3Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2016 - 05/2011
3Phenobarbital (Luminal)FDA Link
09/2015 - 08/2011
3Protein Isoforms (Isoforms)IBA
05/2014 - 06/2003
3Estrogen Receptor Modulators (Antiestrogen)IBA
06/2012 - 05/2003
3fulvestrant (Faslodex)FDA Link
05/2012 - 05/2003
3Steroid Receptors (Steroid Receptor)IBA
03/2012 - 05/2009
3DNA (Deoxyribonucleic Acid)IBA
08/2011 - 04/2011
3Carbon MonoxideIBA
07/2011 - 12/2008
3Phosphotransferases (Kinase)IBA
01/2010 - 01/2005
3TamoxifenFDA LinkGeneric
08/2009 - 05/2003
2Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
01/2016 - 05/2011
2Biological Markers (Surrogate Marker)IBA
09/2015 - 01/2013
1Ribosomal Protein S6IBA
09/2015
1Histone Deacetylase InhibitorsIBA
06/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
05/2014
1Liposomes (Liposome)IBA
05/2014
1albumin-bound paclitaxelFDA Link
05/2014
1130-nm albumin-bound paclitaxelIBA
05/2014
1Hexachlorobenzene (HCB)IBA
05/2013
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2012
1Cyclin D1IBA
05/2012
1Keratin-8 (Keratin 8)IBA
03/2012
1laminin 1IBA
03/2012
1Sirolimus (Rapamycin)FDA Link
03/2012
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
03/2012
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
03/2012
1Yohimbine (Yocon)IBA
07/2011
1ThymidineIBA
07/2011
1Clonidine (ST 155)FDA LinkGeneric
07/2011
1CatecholaminesIBA
07/2011
1progesterone receptor AIBA
04/2011
1decitabine (5-aza-2'-deoxycytidine)FDA Link
04/2011
1NAD (NADH)IBA
10/2010
1Apoptosis Inducing FactorIBA
10/2010
1Laminin (Merosin)IBA
10/2010
1Caspase 9IBA
10/2010
1matrigelIBA
01/2010
1Hormone AntagonistsIBA
01/2010
1PD 98059IBA
01/2010
1PlasticsIBA
01/2010
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
01/2010
1Estradiol (Estrace)FDA LinkGeneric
05/2009
1beta CateninIBA
01/2006
1Epidermal Growth Factor (EGF)IBA
03/2005
1Keratins (Keratin)IBA
03/2005
1OligodeoxyribonucleotidesIBA
01/2005
1Antisense OligonucleotidesIBA
01/2005
1Bromodeoxyuridine (BrdU)IBA
01/2005
1RNA (Ribonucleic Acid)IBA
06/2003
1Raloxifene (Evista)FDA Link
05/2003
1Selective Estrogen Receptor Modulators (SERM)IBA
05/2003

Therapy/Procedure

5Heterologous Transplantation (Xenotransplantation)
09/2015 - 06/2012
2Aftercare (After-Treatment)
01/2016 - 05/2002
2Isogeneic Transplantation
02/2004 - 05/2002
1Drug Therapy (Chemotherapy)
05/2014
1Injections
01/2013
1Contraception (Birth Control)
05/2012
1Lasers (Laser)
08/2011
1Transplants (Transplant)
06/2009
1Transplantation (Transplant Recipients)
06/2003